Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Pain and Symptom Management
|
April 2, 2016
Reply to Meijler
Andrew Davies, Gill Mundin,
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 26, 2018
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers
Martin Jönsson, Gill Mundin, Michael Sumner
Addiction (Abingdon, England)
|
April 22, 2017
Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal
Gill Mundin, Rebecca McDonald, Kevin Smith, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 16, 2023
Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers
Sanjeeva Dissanayake, Gill Mundin, Jo Woodward, et al.
Journal of Pain and Symptom Management
|
December 27, 2015
The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain
Andrew Davies, Gill Mundin, Joanna Vriens, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
May 1, 2012
Low absolute bioavailability of oral naloxone in healthy subjects
Kevin Smith, Michael Hopp, Gill Mundin, et al.
Clinical Therapeutics
|
December 26, 2008
Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers
Kevin Smith, Michael Hopp, Gill Mundin, et al.
Addiction (Abingdon, England)
|
November 17, 2017
Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study
Rebecca McDonald, Ulrike Lorch, Jo Woodward, et al.
British Journal of Clinical Pharmacology
|
June 22, 2021
Pharmacokinetics and brain σ1 receptor occupancy of MR309, a selective σ1 receptor antagonist
Eugenii A Rabiner, Kevin Smith, Carla Bennett, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
June 30, 2018
Pharmacokinetics of Tramadol and Celecoxib in Japanese and Caucasian Subjects Following Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label Study
Helen Dooner, Gill Mundin, Sabine Mersmann, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Pain and Symptom Management
|
April 2, 2016
Reply to Meijler
Andrew Davies, Gill Mundin,
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 26, 2018
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers
Martin Jönsson, Gill Mundin, Michael Sumner
Addiction (Abingdon, England)
|
April 22, 2017
Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal
Gill Mundin, Rebecca McDonald, Kevin Smith, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery
|
February 16, 2023
Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers
Sanjeeva Dissanayake, Gill Mundin, Jo Woodward, et al.
Journal of Pain and Symptom Management
|
December 27, 2015
The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain
Andrew Davies, Gill Mundin, Joanna Vriens, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
May 1, 2012
Low absolute bioavailability of oral naloxone in healthy subjects
Kevin Smith, Michael Hopp, Gill Mundin, et al.
Clinical Therapeutics
|
December 26, 2008
Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers
Kevin Smith, Michael Hopp, Gill Mundin, et al.
Addiction (Abingdon, England)
|
November 17, 2017
Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study
Rebecca McDonald, Ulrike Lorch, Jo Woodward, et al.
British Journal of Clinical Pharmacology
|
June 22, 2021
Pharmacokinetics and brain σ1 receptor occupancy of MR309, a selective σ1 receptor antagonist
Eugenii A Rabiner, Kevin Smith, Carla Bennett, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
June 30, 2018
Pharmacokinetics of Tramadol and Celecoxib in Japanese and Caucasian Subjects Following Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label Study
Helen Dooner, Gill Mundin, Sabine Mersmann, et al.
Page
of 2